Oct 11, 2024, 19:37
María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer
María Natalia Gandur Quiroga recently shared a post on LinkedIn:
“Study Uncovers Mutations and DNA Structures Driving Bladder Cancer.
- New mutations and DNA structures drive bladder cancer, according to a study from Weill Cornell Medicine and the New York Genome Center.
- APOBEC3 antiviral enzymes mutate DNA, triggering early-stage bladder cancer.
- Cisplatin chemotherapy causes bursts of mutations, helping cancer cells resist treatment.
- Extrachromosomal circular DNA (ecDNA) promotes therapy resistance in bladder cancer.
- This study highlights new therapeutic strategies for a hard-to-treat cancer.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 14:05
Nov 14, 2024, 13:49
Nov 14, 2024, 13:44
Nov 14, 2024, 13:37
Nov 14, 2024, 13:32
Nov 14, 2024, 13:29